(+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) PRODUCES LONG-TERM REDUCTIONS IN BRAIN 5-HYDROXYTRYPTAMINE IN RATS

被引:31
|
作者
MOKLER, DJ
ROBINSON, SE
ROSECRANS, JA
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,BOX 613,MCV STN,RICHMOND,VA 23298
[2] UNIV NEW ENGLAND,DEPT PHARMACOL,BIDDEFORD,ME 04005
关键词
D O I
10.1016/0014-2999(87)90441-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:265 / 268
页数:4
相关论文
共 50 条
  • [41] The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes
    Jaehne, Emily Joy
    Salem, Abdallah
    Irvine, Rodney James
    PSYCHOPHARMACOLOGY, 2008, 201 (02) : 161 - 170
  • [42] 3,4-methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain
    Darvesh, AS
    Shankaran, M
    Gudelsky, GA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01): : 138 - 144
  • [43] Dose concentration and spatial memory and brain mitochondrial function association after 3,4-methylenedioxymethamphetamine (MDMA) administration in rats
    G. Taghizadeh
    H. Mehdizadeh
    H. Lavasani
    Y. Hosseinzadeh Ardakani
    A. Foroumadi
    Z. Halvaei Khankahdani
    A. Moshtagh
    J. Pourahmad
    M. Sharifzadeh
    M. R. Rouini
    Archives of Toxicology, 2020, 94 : 911 - 925
  • [44] Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
    F. X. Vollenweider
    S. Remensberger
    D. Hell
    M. A. Geyer
    Psychopharmacology, 1999, 143 : 365 - 372
  • [45] THE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) ON MONOAMINERGIC SYSTEMS IN THE RAT-BRAIN
    STONE, DM
    STAHL, DC
    HANSON, GR
    GIBB, JW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 128 (1-2) : 41 - 48
  • [46] Dose concentration and spatial memory and brain mitochondrial function association after 3,4-methylenedioxymethamphetamine (MDMA) administration in rats
    Taghizadeh, G.
    Mehdizadeh, H.
    Lavasani, H.
    Ardakani, Y. Hosseinzadeh
    Foroumadi, A.
    Khankandani, Z. Halvaei
    Moshtagh, A.
    Pourahmad, J.
    Sharifzadeh, M.
    Rouini, M. R.
    ARCHIVES OF TOXICOLOGY, 2020, 94 (03) : 911 - 925
  • [47] The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine
    Steinkellner, Thomas
    Freissmuth, Michael
    Sitte, Harald H.
    Montgomery, Therese
    BIOLOGICAL CHEMISTRY, 2011, 392 (1-2) : 103 - 115
  • [48] RESPONSES OF BRAIN NEUROTENSIN-LIKE IMMUNOREACTIVITY TO 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA)
    MERCHANT, K
    LETTER, AA
    STONE, DM
    GIBB, JW
    HANSON, GR
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 1060 - 1060
  • [49] Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats
    Schindler, Charles W.
    Thorndike, Eric B.
    Blough, Bruce E.
    Tella, Srihari R.
    Goldberg, Steven R.
    Baumann, Michael H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (01) : 83 - 91
  • [50] The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats
    Mechan, AO
    Esteban, B
    O'Shea, E
    Elliott, JM
    Colado, MI
    Green, AR
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 170 - 180